

Itâs no secret that Iâm a big fan of buy and hold investing. In fact, I believe it is the best way for investors to grow their wealth.
In light of this, every so often I like to demonstrate how successful this investment strategy can be by picking out a number of popular ASX shares to see how much a single $20,000 investment 10 years ago would be worth today.
And while you might think that you would need to unearth some rising stars to generate big returns, thatâs not actually the case.
For example, listed below are three ASX shares that have comprehensively beaten the market and were no secret to investors back in 2013. Letâs see how investments in these shares fared:
Goodman Group (ASX: GMG)
This integrated industrial property companyâs strategy of building sustainable properties that are close to consumers and provide essential infrastructure for the digital economy has been a huge success. Demand has been so strong, that Goodman has delivered stellar earnings growth over the last decade. This has ultimately led to this ASX share generating an average total return of 17.23% per annum since 2013. This would have seen a $20,000 investment turn into almost $100,000 over the period.
Macquarie Group Ltd (ASX: MQG)
This investment bank has been a strong performer for investors over the last decade. During this time, Macquarieâs shares have smashed the market with a total average return of 19.25% per annum. This would have turned a $20,000 investment 10 years ago into almost $120,000 today.
ResMed Inc. (ASX: RMD)
Thanks to the growing awareness of sleep disorders and this medical device companyâs industry-leading solutions, it has reported consistently solid sales and earnings growth over the 2010s and now into the 2020s. This has led to this ASX share providing investors with an average total return of 22.26% per annum since 2013. This means that a $20,000 investment back then would have grown to be worth almost $150,000 now.
The post $20,000 invested in these ASX shares 10 years ago is worth how much now? appeared first on The Motley Fool Australia.
Scott Phillips reveals 5 “Bedrock” Stocks
Scott Phillips has just revealed 5 companies he thinks could form the bedrock of every new investor portfolio…
Especially if they’re aiming to beat the market over the long term.
Are you missing these cornerstone stocks in your portfolio?
Get details here.
See The 5 Stocks
*Returns as of January 5 2023
(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}
setButtonColorDefaults(“#0095C8”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#0095C8”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()
More reading
- Experts say these are the ASX 200 blue chip shares to buy now
- House prices are tanking. Will ASX property shares go down with them?
- ASX 200 healthcare share charges higher as quarterly revenue surges
- Buy Macquarie and this ASX 200 dividend share: analysts
- 5 things to watch on the ASX 200 on Friday
Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended ResMed. The Motley Fool Australia has positions in and has recommended ResMed. The Motley Fool Australia has recommended Macquarie Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.
from The Motley Fool Australia https://ift.tt/4NtnCdq
Leave a Reply